Trademark Overview
On Tuesday, October 25, 2022, a trademark application was filed for TCAR with the United States Patent and Trademark Office. The USPTO has given the TCAR trademark a serial number of 97647785. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 28, 2023. This trademark is owned by IMGEN BIOSCIENCES INCORPORATION. The TCAR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, infectious diseases, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical T cell receptors, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, infectious diseases, inflammation and inflammatory diseases
Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, infectious diseases, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, infectious diseases, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
